Education
About Us
Working with TipRanks
Follow Us
Enovis (ENOV)
NYSE:ENOV
ENOV Stock Chart & Stats
Day’s Range― - ―
52-Week Range$25.47 - $49.83
Previous CloseN/A
Volume391.51K
Average Volume (3M)1.68M
Market Cap
$1.47B
Enterprise Value$3.35B
Total Cash (Recent Filing)$38.46M
Total Debt (Recent Filing)$1.46B
Price to Earnings (P/E)―
Beta1.24
Next Earnings
Oct 30, 2025EPS Estimate
0.65Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.79
Shares Outstanding57,123,050
10 Day Avg. Volume1,338,306
30 Day Avg. Volume1,683,401
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.95
Price to Sales (P/S)1.15
P/FCF Ratio-36.09
Enterprise Value/Market Cap2.27
Enterprise Value/Revenue1.56
Enterprise Value/Gross Profit2.75
Enterprise Value/Ebitda-7.09
Forecast
1Y Price Target
$54.86Price Target Upside92.90% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Bulls Say, Bears Say
Bulls Say
Financial PerformanceEnovis reported a solid Q2 beat, with 11% reported growth for Recon and 5% reported growth for P&R, driven by strong growth in global extremities and hips & knees.
Guidance And StrategyENOV raised its FY25 guidance across revenue, organic growth, EBITDA, and EPS, supported by operational execution, FX tailwinds, and decreased expected tariff impacts.
ValuationENOV is working to create a cohesive unit of its Recon acquisitions, driving both an organic R&D engine and operational discipline, with the stock trading at less than half the valuation of its mid-cap MedTech peers, suggesting it is significantly undervalued.
Bears Say
Organic GrowthOrganic revenue growth slowed to 5.1% in 2Q25 from 10.4% in 1Q25.
Peer ComparisonThe price target is lowered to $49 due to peer multiple contraction.
Product Launch DelaysThe next-gen ARVIS launch has been delayed by approximately 6 months to incorporate enhancements, although surgeon excitement around the platform remains high.
Enovis News
ENOV FAQ
What was Enovis’s price range in the past 12 months?
Enovis lowest stock price was $25.46 and its highest was $49.83 in the past 12 months.
What is Enovis’s market cap?
Enovis’s market cap is $1.47B.
When is Enovis’s upcoming earnings report date?
Enovis’s upcoming earnings report date is Oct 30, 2025 which is in 81 days.
How were Enovis’s earnings last quarter?
Enovis released its earnings results on Aug 07, 2025. The company reported $0.79 earnings per share for the quarter, beating the consensus estimate of $0.719 by $0.071.
Is Enovis overvalued?
According to Wall Street analysts Enovis’s price is currently Undervalued.
Does Enovis pay dividends?
Enovis does not currently pay dividends.
What is Enovis’s EPS estimate?
Enovis’s EPS estimate is 0.65.
How many shares outstanding does Enovis have?
Enovis has 57,123,050 shares outstanding.
What happened to Enovis’s price movement after its last earnings report?
Enovis reported an EPS of $0.79 in its last earnings report, beating expectations of $0.719. Following the earnings report the stock price went up 10.714%.
Which hedge fund is a major shareholder of Enovis?
Currently, no hedge funds are holding shares in ENOV
Enovis Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$54.86 (92.90% Upside)
$54.86 (92.90% Upside)
Blogger Sentiment
Bullish
ENOV Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 807.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 0.4%
Last 30 Days ▼ 0.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.70%
12-Months-Change
Fundamentals
Return on Equity
-28.31%
Trailing 12-Months
Asset Growth
-7.73%
Trailing 12-Months
Company Description
Enovis
Enovis Corporation (ENOV) is a diversified medical technology company focused on developing innovative solutions in the field of healthcare. The company operates primarily in the medical technology sector, offering a range of products and services aimed at enhancing patient care and improving clinical outcomes. Enovis specializes in manufacturing and distributing advanced medical devices and equipment, particularly in the areas of orthopedic solutions, rehabilitation, and surgical technologies. Through its commitment to innovation and quality, Enovis serves a global customer base, including hospitals, clinics, and healthcare professionals.
ENOV Company Deck
ENOV Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong start to the fiscal year 2025 with significant growth in key segments, successful product launches, and improved financial metrics. However, tariff and currency challenges pose potential risks to margins and require strategic mitigation.View all ENOV earnings summariesENOV Stock 12 Month Forecast
Average Price Target
$54.86
▲(92.90% Upside)
Technical Analysis
Ownership Overview
2.12% Insiders
45.74% Mutual Funds
0.64% Other Institutional Investors
21.80% Public Companies and
Individual Investors